(Q57909898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

K Gharehbaghi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Fritzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Woody

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Srivastava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

B van't Riet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

H N Jayaram

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

H L Elford

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

63-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686113

26 October 2019

exact match

0 references

cites work

Enzymology of cancer cells (first of two parts).

1 reference

12 December 2020

Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma

1 reference

12 December 2020

Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.

1 reference

12 December 2020

Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.

1 reference

12 December 2020

Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells

1 reference

12 December 2020

Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells

1 reference

12 December 2020

Regulation of ribonucleotide reductase activity in mammalian cells

1 reference

12 December 2020

The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).

1 reference

12 December 2020

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

12 December 2020

Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives

1 reference

12 December 2020

Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells

1 reference

12 December 2020

Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime

1 reference

12 December 2020

Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors

1 reference

12 December 2020

Formation of deoxycytidine phosphates from cytidine phosphates in extracts from Escherichia coli

1 reference

12 December 2020

Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee

1 reference

12 December 2020

Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents

1 reference

12 December 2020

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee

1 reference

12 December 2020

Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells

1 reference

12 December 2020

Ribonucleotide reductase as a chemotherapeutic target

1 reference

12 December 2020

Role of ribonucleotide reductase in expression in the neoplastic program.

1 reference

12 December 2020

New ribonucleotide reductase inhibitors with antineoplastic activity

1 reference

12 December 2020

Combination chemotherapy directed at the components of nucleoside diphosphate reductase

1 reference

12 December 2020

Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells.

1 reference

12 December 2020

Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8174204%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference